A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Nine researchers from the University of Cambridge are among 46 world leading UK researchers who have been elected to the prestigious Fellowship of the Academy of Medical Sciences.
The Cambridge Research Institute (CRI) is driving the development of new approaches for the early detection, prevention and treatment of cancer.
© 2026 University of Cambridge